192 related articles for article (PubMed ID: 24237646)
1. Gemcitabine-induced thrombotic microangiopathy.
Richmond J; Gilbar P; Abro E
Intern Med J; 2013 Nov; 43(11):1240-2. PubMed ID: 24237646
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.
Leal F; Macedo LT; Carvalheira JB
J Chemother; 2014 Jun; 26(3):169-72. PubMed ID: 24091354
[TBL] [Abstract][Full Text] [Related]
3. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
[TBL] [Abstract][Full Text] [Related]
4. Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis.
Thomas JG; Sethi S; Norby SM
Am J Kidney Dis; 2011 May; 57(5):799-802. PubMed ID: 21411201
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.
Daviet F; Rouby F; Poullin P; Moussi-Francès J; Sallée M; Burtey S; Mancini J; Duffaud F; Sabatier R; Pourroy B; Grandvuillemin A; Grange S; Frémeaux-Bacchi V; Coppo P; Micallef J; Jourde-Chiche N
Br J Clin Pharmacol; 2019 Feb; 85(2):403-412. PubMed ID: 30394581
[TBL] [Abstract][Full Text] [Related]
6. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?].
Charmetant X; Jolivot A; Fournier T; Puthet JC; Cassier P; Lemoine S; Juillard L
Nephrol Ther; 2017 Jun; 13(4):251-254. PubMed ID: 28499586
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
Katagiri D; Hinoshita F
CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
[TBL] [Abstract][Full Text] [Related]
8. ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.
Bittar PG; Nickolich MS; Onwuemene OA
J Clin Apher; 2018 Jun; 33(3):423-426. PubMed ID: 28940604
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.
Grall M; Daviet F; Chiche NJ; Provot F; Presne C; Coindre JP; Pouteil-Noble C; Karras A; Guerrot D; François A; Benhamou Y; Veyradier A; Frémeaux-Bacchi V; Coppo P; Grangé S
BMC Nephrol; 2021 Jul; 22(1):267. PubMed ID: 34284729
[TBL] [Abstract][Full Text] [Related]
10. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T
BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.
Mir-Bonafé JM; Román-Curto C; Santos-Briz A; Cañueto J; Fernández-López E; Unamuno P
J Cutan Pathol; 2012 Jul; 39(7):707-11. PubMed ID: 22612305
[TBL] [Abstract][Full Text] [Related]
12. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-induced renal thrombotic microangiopathy.
Horino T; Inotani S; Ishihara M; Terada Y
Nephrology (Carlton); 2022 Aug; 27(8):724-725. PubMed ID: 35429056
[No Abstract] [Full Text] [Related]
14. Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma.
Willemsen AE; van Herpen CM; Wesseling P; Bult P; van Laarhoven HW
Acta Oncol; 2011 Apr; 50(3):462-5. PubMed ID: 20799915
[No Abstract] [Full Text] [Related]
15. [Gemcitabine-induced thrombotic microangiopathy].
Teixeira L; Debourdeau P; Zammit C; Estival JL; Pavic M; Colle B
Presse Med; 2002 Apr; 31(16):740-2. PubMed ID: 12148351
[TBL] [Abstract][Full Text] [Related]
16. [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer].
Kashima H; Minami R; Ozawa T; Matsumoto A; Kimura Y; Takeda Y; Ueo T; Okano A; Kusumi F; Ohana M
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(3):259-266. PubMed ID: 35264490
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].
Rogier T; Gerfaud-Valentin M; Pouteil-Noble C; Taleb A; Guillet M; Noel A; Broussolle C; Sève P
Rev Med Interne; 2016 Oct; 37(10):701-704. PubMed ID: 26833144
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-associated thrombotic microangiopathy.
Humphreys BD; Sharman JP; Henderson JM; Clark JW; Marks PW; Rennke HG; Zhu AX; Magee CC
Cancer; 2004 Jun; 100(12):2664-70. PubMed ID: 15197810
[TBL] [Abstract][Full Text] [Related]
19. Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review.
Allard J; Bonnet M; Laurent L; Bouattour M; Gagaille MP; Leclerc V
Eur J Clin Pharmacol; 2022 Jul; 78(7):1087-1093. PubMed ID: 35507073
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic agents and thrombotic microangiopathy.
Garcia G; Atallah JP
J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
